Linda I Luczak

Linda I. Luczak serves as a key procurement professional responsible for managing complex acquisitions within a federal entity focused on biomedical and industrial infrastructure. She oversees the full lifecycle of contracting actions, from requirements definition through contract award and administration, ensuring compliance with federal acquisition regulations and mission-aligned outcomes. Her portfolio centers on high-value scientific and medical products, with a strong emphasis on manufacturing and facility-related procurements that support public health and operational readiness. Luczak’s work directly enables the agency’s capacity to deliver critical biomedical resources and maintain mission-critical infrastructure. Her contractor relationships are primarily with manufacturers and technical service providers specializing in pharmaceuticals, biological products, and medical instrumentation. While no single vendor dominates her award history, she consistently engages with mid-to-large-scale producers capable of meeting stringent regulatory standards, including cGMP and FDA-compliant production environments. She also partners with specialized construction firms for industrial facility upgrades and professional associations that provide technical advisory services, reflecting a balanced approach between direct product procurement and enabling infrastructure support. Luczak’s contracting patterns show a strong preference for unrestricted competition, with 94.1% of awards issued without set-aside designations. However, she maintains a consistent, albeit modest, commitment to small business participation, with 5.9% of awards directed toward Total Small Business Set-Asides under FAR 19.5. This reflects a strategic balance between ensuring supply chain reliability and fulfilling socioeconomic goals, without compromising on technical or operational requirements. Her primary procurement focus lies in NAICS 325414 (Biological Product Manufacturing) and 325412 (Pharmaceutical Preparation Manufacturing), indicating deep expertise in biologics and sterile drug production. She also procures surgical instruments (339112), industrial construction (236210), and professional services (813920), demonstrating a multidisciplinary understanding of biomedical supply chains and facility-based operations. Her technical domain spans pharmaceutical manufacturing, medical device compliance, and infrastructure support for healthcare delivery systems.